4.6 Article

The Major Determinant for Addition of Tegument Protein pUL48 (VP16) to Capsids in Herpes Simplex Virus Type 1 Is the Presence of the Major Tegument Protein pUL36 (VP1/2)

期刊

JOURNAL OF VIROLOGY
卷 84, 期 3, 页码 1397-1405

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.01721-09

关键词

-

类别

资金

  1. Australian National Health and Medical Research Council [402457, 457315]
  2. Endeavor International Postgraduate Research Scholarship and International Postgraduate Award

向作者/读者索取更多资源

In this study a number of herpes simplex virus type 1 (HSV-1) proteins were screened, using a yeast-two-hybrid assay, for interaction with the tegument protein pUL48 (VP16). This approach identified interactions between pUL48 and the capsid proteins pUL19 (VP5), pUL38 (VP19C), and pUL35 (VP26). In addition, the previously identified interaction of pUL48 with the major tegument protein pUL36 (VP1/2) was confirmed. All of these interactions, except that of pUL35 and pUL48, could be confirmed using an in vitro pulldown assay. A subsequent pulldown assay with intact in vitro-assembled capsids, consisting of pUL19, pUL38, and pUL18 (VP23) with or without pUL35, showed no binding of pUL48, suggesting that the capsid/pUL48 interactions initially identified were more then likely not biologically relevant. This was confirmed by using a series of HSV-1 mutants lacking the gene encoding either pUL35, pUL36, or pUL37. For each HSV-1 mutant, analysis of purified deenveloped C capsids indicated that only in the absence of pUL36 was there a complete loss of capsid-bound pUL48, as well as pUL37. Collectively, this study shows for the first time that pUL36 is a major factor for addition of both pUL48 and pUL37, likely through a direct interaction of both with nonoverlapping sites in pUL36, to unenveloped C capsids during assembly of HSV-1.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Celine Boutry, Andrew Hastie, Javier Diez-Domingo, Juan Carlos Tinoco, Chong-Jen Yu, Charles Andrews, Jean Beytout, Covadonga Caso, Huey-Shinn Cheng, Hee Jin Cheong, Eun Ju Choo, Dan Curiac, Emmanuel Di Paolo, Marc Dionne, Tamara Eckermann, Meral Esen, Murdo Ferguson, Wayne Ghesquiere, Shinn-Jang Hwang, Thiago Junqueira Avelino-Silva, Pavel Kosina, Chiu-Shong Liu, Jukka Markkula, Beate Moeckesch, Claudia Murta de Oliveira, Dae Won Park, Karlis Pauksens, Paola Pirrotta, Georg Plassmann, Carol Pretswell, Lars Rombo, Bruno Salaun, Johan Sanmartin Berglund, Isabelle Schenkenberger, Tino Schwarz, Meng Shi, Benita Ukkonen, Toufik Zahaf, Cristiano Zerbini, Anne Schuind, Anthony L. Cunningham

Summary: The efficacy against herpes zoster and immune responses to the adjuvanted recombinant zoster vaccine remained high for at least 7 years post-vaccination, with both efficacy and immune responses plateauing at high levels between 5.1 and 7.1 years post-vaccination. These results suggest that the clinical benefit of the vaccine in older adults is sustained long-term.

CLINICAL INFECTIOUS DISEASES (2022)

Article Hematology

COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity

Yandong Shen, Jane A. Freeman, Juliette Holland, Ann Solterbeck, Kartik Naidu, Asha Soosapilla, Paul Downe, Catherine Tang, Ian Kerridge, Lucinda Wallman, Nenna Van Bilsen, Vanessa Milogiannakis, Anouschka Akerman, Gabriela Martins Costa Gomes, Kerrie Sandgren, Anthony L. Cunningham, Stuart Turville, Stephen P. Mulligan

Summary: Chronic lymphocytic leukaemia (CLL) and monoclonal B-cell lymphocytosis (MBL) patients have poor immune response to COVID-19 vaccines, with most of them failing to produce sufficient antibody levels. The patients' treatment status and reduced immune function are associated with vaccine immunization failure.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Microbiology

Herpes simplex virus-1 utilizes the host actin cytoskeleton for its release from axonal growth cones

Kevin Danastas, Ava Larsen, Sophie Jobson, Gerry Guo, Anthony L. Cunningham, Monica Miranda-Saksena

Summary: This study reveals the important role of actin and myosin V in the release of HSV-1 from axon termini. Inhibition of actin polymerization and myosin V significantly reduces the release of the virus. These findings contribute to our understanding of the mechanisms of HSV-1 transmission.

PLOS PATHOGENS (2022)

Article Pathology

Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi

Andrew J. Colebatch, Chandra Adhikari, Russell J. Diefenbach, Robert V. Rawson, Peter M. Ferguson, Helen Rizos, Georgina V. Long, Stanley W. McCarthy, John F. Thompson, James S. Wilmott, Richard A. Scolyer

Summary: Blue nevi involving lymph nodes are benign and often misdiagnosed as metastatic melanoma. This study provides evidence that these blue nevi have a benign clinical behavior and probably represent so-called benign metastasis.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Article Biotechnology & Applied Microbiology

Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling

John J. Park, Ashleigh Stewart, Mal Irvine, Bernadette Pedersen, Zizhen Ming, Matteo S. Carlino, Russell J. Diefenbach, Helen Rizos

Summary: Uveal melanoma, a rare eye cancer, lacks approved therapy for metastatic cases. This study found that the response of uveal melanoma cells to PKC inhibitors varied, and it was not related to the degree of PKC suppression or inhibition of downstream pathways. Instead, uveal melanoma cells showed complex, PKC-independent signaling pathways that contributed to their survival and resistance to targeted therapies.

CANCER GENE THERAPY (2022)

Article Multidisciplinary Sciences

Tissue resident memory T cells inhabit the deep human conjunctiva

Racha Arnous, Sana Arshad, Kerrie Sandgren, Anthony L. Cunningham, Nicole Carnt, Andrew White

Summary: This study aims to investigate the presence of tissue-resident memory T cells (T-RMs) in deeper layers of the healthy human conjunctiva. Using immunofluorescence microscopy, the researchers found CD69(+)T(RM) subsets in all layers of the conjunctiva, with higher densities in the adenoid layer. Interestingly, CD4 T-RMs were more abundant than CD8 T-RMs in the adenoid layer. These findings suggest the presence of defense mechanisms capable of inducing long-term immunogenic memory in the deep conjunctiva.

SCIENTIFIC REPORTS (2022)

Article Oncology

Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA

Russell J. Diefenbach, Jenny H. Lee, Ashleigh Stewart, Alexander M. Menzies, Matteo S. Carlino, Robyn P. M. Saw, Jonathan R. Stretch, Georgina V. Long, Richard A. Scolyer, Helen Rizos

Summary: This study developed a custom panel for detecting TERT promoter mutations in ctDNA from melanoma patients. Analysis of patient samples showed a high detection rate for BRAF, NRAS, and TERT promoter mutations, and the panel demonstrated consistency with tissue biopsies.

FRONTIERS IN ONCOLOGY (2022)

Article Chemistry, Medicinal

Identifying HSV-1 Inhibitors from Natural Compounds via Virtual Screening Targeting Surface Glycoprotein D

Jiadai Wu, Helen Power, Monica Miranda-Saksena, Peter Valtchev, Aaron Schindeler, Anthony L. Cunningham, Fariba Dehghani

Summary: This study identified potential antiviral compounds using computational methods and experimental evaluations, with one active compound showing a novel antiviral mechanism of action.

PHARMACEUTICALS (2022)

Article Anesthesiology

Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials

Joon Hyung Kim, Robert Johnson, Martina Kovac, Anthony L. Cunningham, Mohamed Amakrane, Keith M. Sullivan, Alemnew F. Dagnew, Desmond Curran, Anne Schuind

Summary: Herpes zoster and HZ-associated pain significantly impact the quality of life of older and immunocompromised adults. The adjuvanted recombinant zoster vaccine has been proven effective in preventing HZ and reducing pain severity in healthy and immunocompromised adults. It also reduces the duration of HZ-associated pain and pain medication use, thus improving patients' quality of life.
Letter Immunology

Defining the landscape of human epidermal mononuclear phagocytes

Kirstie M. Bertram, Thomas R. O'Neil, Erica E. Vine, Heeva Baharlou, Anthony L. Cunningham, Andrew N. Harman

IMMUNITY (2023)

Article Medicine, General & Internal

Emergence and antibody evasion of BQ, BA.2.75 and SARS- CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level

Anouschka Akerman, Vanessa Milogiannakis, Tyra Jean, Camille Esneau, Mariana Ruiz Silva, Timothy Ison, Christina Fichter, Joseph A. Lopez, Deborah Chandra, Zin Naing, Joanna Caguicla, Daiyang Li, Gregory Walker, Supavadee Amatayakul-Chantler, Nathan Roth, Sandro Manni, Thomas Hauser, Thomas Barnes, Anna Condylios, Malinna Yeang, Maureen Wong, Charles S. P. Foster, Kenta Sato, Sharon Lee, Yang Song, Lijun Mao, Allison Sigmund, Amy Phu, Ann Marie Vande More, Stephanie Hunt, Mark Douglas, Ian Caterson, Warwick Britton, Kerrie Sandgren, Rowena Bull, Andrew Lloyd, Jamie Triccas, Stuart Tangye, Nathan W. Bartlett, David Darley, Gail Matthews, Damien J. Stark, Kathy Petoumenos, William D. Rawlinson, Ben Murrell, Fabienne Brilot, Anthony L. Cunningham, Anthony D. Kelleher, Anupriya Aggarwal, Stuart G. Turville

Summary: This study monitored the neutralization potency and breadth of antibodies against Omicron variants over time. The findings show that the antibody response to Omicron variants has been maturing, with increased breadth observed even to variants that were not yet in circulation.

EBIOMEDICINE (2023)

Article Biochemical Research Methods

OMIP-096: A 24-color flow cytometry panel to identify and characterize CD4+and CD8+tissue-resident T cells in human skin, intestinal, and type II mucosal tissue

Thomas R. O'Neil, Andrew N. Harman, Anthony L. Cunningham, Najla Nasr, Kirstie M. Bertram

Summary: Understanding the role of human immune cells in tissue is crucial. We developed a 24-color flow cytometry panel to analyze CD4(+) and CD8(+) tissue-resident memory T cells from human tissues. We carefully selected antibody clones and evaluated the effect of enzymatic digestion to ensure accurate marker expression.

CYTOMETRY PART A (2023)

Article Multidisciplinary Sciences

Redefining the human corneal immune compartment using dynamic intravital imaging

Laura E. Downie, Xinyuan Zhang, Mengliang Wu, Senuri Karunaratne, Joon Keit Loi, Kirthana Senthil, Sana Arshad, Kirstie Bertram, Anthony L. Cunningham, Nicole Carnt, Scott N. Mueller, Holly R. Chinnery

Summary: The healthy human cornea contains immune cells that are commonly presumed to be dendritic cells, but the researchers found that many of these immune cells are actually lymphocytes. These corneal immune cells exhibit rapid, persistent motility and interact with other cells. The behavior of these immune cells can be altered in response to acute and chronic inflammatory stimuli, which can be modulated by therapeutic intervention.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Microbiology

Interferon inhibits the release of herpes simplex virus-1 from the axons of sensory neurons

Kevin Danastas, Gerry Guo, Jessica Merjane, Nathan Hong, Ava Larsen, Monica Miranda-Saksena, Anthony L. Cunningham

Summary: This study explores the effects of interferons (IFNs) on herpes simplex virus-1 (HSV-1) and reveals that IFNs have the potential to block virus release from nerve endings, thereby preventing transmission into the skin. The study also highlights the potential wider antiviral effects of IFN-γ in neurons, suggesting its role in HSV-1 reactivation. These findings identify new targets for the development of immunotherapies to impede HSV-1 spread from nerves to the skin.
Article Medicine, Research & Experimental

The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memo CD4+ T cells

Gabriel Duette, Bonnie Hiener, Hannah Morgan, Fernando G. Mazur, Vennila Mathivanan, Bethany A. Horsburgh, Katie Fisher, Orion Tong, Eunok Lee, Haelee Ahn, Ansari Shaik, Remi Fromentin, Rebecca Hoh, Charline Bacchus-Souffan, Najla Nasr, Anthony L. Cunningham, Peter W. Hunt, Nicolas Chomont, Stuart G. Turville, Steven G. Deeks, Anthony D. Kelleher, Timothy E. Schlub, Sarah Palmer

Summary: Through studying CD4(+) T cells of HIV-1 patients, the importance of effector memory T cells in the persistence of HIV-1 has been identified, and Nef has been suggested as a potential therapeutic target.

JOURNAL OF CLINICAL INVESTIGATION (2022)

暂无数据